ZBIO
NASDAQ
$30.70
Zenas Biopharma Inc (ZBIO)
Zenas BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies. The company is headquartered in Waltham, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $42.12 (+37.20%)
Market Cap
$1.83B
Free Cash Flow Yield
-11.47%
Beta (5Y)
1.24
Price Chart
Valuation
Market Cap$1.83B
P/S119.50
P/B5.41
Profitability
Gross Profit (TTM)-$194M
EBITDA-$423M
EPS-$8.17
Financial Health
Free Cash Flow Yield-11.47%
Growth & Risk
Beta (5Y)1.24
Sharpe Ratio1.34